Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Mitacs brings innovation to more people in more places across Canada and around the world.
Learn MoreWe work closely with businesses, researchers, and governments to create new pathways to innovation.
Learn MoreNo matter the size of your budget or scope of your research, Mitacs can help you turn ideas into impact.
Learn MoreThe Mitacs Entrepreneur Awards and the Mitacs Awards celebrate inspiring entrepreneurs and innovators who are galvanizing cutting-edge research across Canada.
Learn MoreDiscover the people, the ideas, the projects, and the partnerships that are making news, and creating meaningful impact across the Canadian innovation ecosystem.
Learn MoreNlrx1, belongs to NLR family of intracellular sensors that regulate mayor cellular pathway including cell death and inflammation. Previous research implicated Nlrx1 in regulation of autophagy and reactive oxygen species production during viral infection. In addition most recent publication implicated Nlrx1 in regulation of the cell death in fibroblasts cultures. Our preliminary data show that Nlrx1-/- mice are more prone to develop experimental autoimmune encephalomyelitis. The increased susceptibility of the Nlrx1-/- mice is associated with increased (2 fold) inflammatory infiltrate and induced astrogliosis (2 fold) compared to WT control. We also noted a drastic reduction (7 fold) in neuronal content in the spinal cords of Nlrx1-/- compared to WT mice. Such profound differences in the neuronal content cannot be explained by magnitude of the inflammatory response. Therefore, the cell death phenomenon that we observed has to be neuron specific.
Aim 1 is to characterize inflammation-induced cell death in primary cultures from WT and Nlrx1-/-mice.
Hypothesis: Nlrx1 inhibits inflammation-induced neuronal death. We will study inflammation-induced cell death in the mixed brain cultures that contain neurons, astrocytes, and microglia. In addition we will use oxygen/glucose deprivation model of stroke to screen several drag candidates. We will assess cell death by immunohistochemistry, flow cytometry, and Western blotting.
The results of these studies will lay foundation for development of new therapeutical agents to treat neurodegenerative diseases
Denis Gris
Emilia Gonzalez Avila
Medicine
Globalink
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.